Immune Checkpoints: Convergence of Cancer Treatment & HIV Cure Volberding, Paul Volberding, Paul Less Oncology Times. 38(4):1,4-4, February 25, 2016. Favorites PDF Get Content & Permissions Free
Paradigm Shift in Myeloma Care Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 38(4):1,5-5, February 25, 2016. Favorites PDF Get Content & Permissions Free
Proton Therapy for Pediatric Cancer—A Proliferation in the Works? Neff Newitt, Valerie Neff Newitt, Valerie Less Oncology Times. 38(4):1,6-7, February 25, 2016. Favorites PDF Get Content & Permissions Free
How We Treat Patients with Chronic Myeloid Leukemia Jabbour, Elias; Kantarjian, Hagop M. Jabbour, Elias; Kantarjian, Hagop M. Less Oncology Times. 38(4):8-9, February 25, 2016. Favorites PDF Get Content & Permissions Free
POINT-COUNTERPOINT: To Maintain or Not to Maintain in Myeloma Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 38(4):10-12, February 25, 2016. Favorites PDF Get Content & Permissions Free
‘What's New in Oncology’ from UpToDate® Less Oncology Times. 38(4):13, February 25, 2016. Favorites PDF Get Content & Permissions Free
Prostate Cancer: Shorter Radiation Regimen Gets Same Results as Conventional Treatment Susman, Ed Susman, Ed Less Oncology Times. 38(4):14, February 25, 2016. Favorites PDF Get Content & Permissions Free
No Let Down: Viagra Does Not Increase Prostate Cancer Recurrences Susman, Ed Susman, Ed Less Oncology Times. 38(4):15, February 25, 2016. Favorites PDF Get Content & Permissions Free
Prostate Radiation Considered in Inflammatory Bowel Disease Patients Susman, Ed Susman, Ed Less Oncology Times. 38(4):16, February 25, 2016. Favorites PDF Get Content & Permissions Free
Radioisotope Lowers Progression Risk with Manageable Toxicity in Patients with Midgut NET Carlson, Robert H. Carlson, Robert H. Less Oncology Times. 38(4):22, February 25, 2016. Favorites PDF Get Content & Permissions Free
Short Course Neoadjuvant Radiotherapy Improves Overall Survival in Advanced Rectal Cancer Carlson, Robert H. Carlson, Robert H. Less Oncology Times. 38(4):23-24, February 25, 2016. Favorites PDF Get Content & Permissions Free
Opportunistic Pneumonia Infections May Present with Dose Dense Breast Cancer Therapy Susman, Ed Susman, Ed Less Oncology Times. 38(4):26, February 25, 2016. Favorites PDF Get Content & Permissions Free
Late Recurrence of Endometrial Cancer Observed in Only 1% of Women Susman, Ed Susman, Ed Less Oncology Times. 38(4):27, February 25, 2016. Favorites PDF Get Content & Permissions Free
10-year Survival ‘Excellent’ for Men with Early Stage Seminoma Treated with Chemo or RT Susman, Ed Susman, Ed Less Oncology Times. 38(4):28, February 25, 2016. Favorites PDF Get Content & Permissions Free
Bone Loss Highly Prevalent Among Patients on Aromatase Inhibitors Susman, Ed Susman, Ed Less Oncology Times. 38(4):29, February 25, 2016. Favorites PDF Get Content & Permissions Free
Those ‘Early Bird’ Dinners Might Help Prevent Breast Cancer Recurrence Susman, Ed Susman, Ed Less Oncology Times. 38(4):30, February 25, 2016. Favorites PDF Get Content & Permissions Free
Aromatase Inhibitors Reduce Contralateral Breast Cancer Susman, Ed Susman, Ed Less Oncology Times. 38(4):31, February 25, 2016. Favorites PDF Get Content & Permissions Free
Text Messaging Helps Keep Women Compliant with Aromatase Inhibitor Therapy Susman, Ed Susman, Ed Less Oncology Times. 38(4):32-33, February 25, 2016. Favorites PDF Get Content & Permissions Free
Breast Reconstruction Delay Suggested in Inflammatory Disease Susman, Ed Susman, Ed Less Oncology Times. 38(4):33,35-35, February 25, 2016. Favorites PDF Get Content & Permissions Free
POINT-COUNTERPOINT: HDAC Inhibitors Hit a Single, Not a Home Run, Against Myeloma Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 38(4):34-35, February 25, 2016. Favorites PDF Get Content & Permissions Free
Lifelong Care Needed by Survivors of Retinoblastoma, Low-Grade Gliomas Carlson, Robert H. Carlson, Robert H. Less Oncology Times. 38(4):38-39, February 25, 2016. Favorites PDF Get Content & Permissions Free
FDA's Breakthrough Therapy Status to Venetoclax Combo Therapy for CLL Less Oncology Times. 38(4):9, February 25, 2016. Favorites PDF Get Content & Permissions Free
FDA Approves Opdivo-Yervoy Combo, Opdivo Single-Agent Therapy for New Indications in Metastatic Melanoma Less Oncology Times. 38(4):24, February 25, 2016. Favorites PDF Get Content & Permissions Free
Editorial: Building on Excellence Nace, Lynn Nace, Lynn Less Oncology Times. 38(4):7, February 25, 2016. Favorites PDF Get Content & Permissions Free
View from the Other Side of the Stethoscope: Advocacy—The Legacy of Ellen Stovall Harpham, Wendy S. Harpham, Wendy S. Less Oncology Times. 38(4):17, February 25, 2016. Favorites PDF Get Content & Permissions Free
VOICES: QOL Awareness Suggested for Managing Prostate Cancer Survivors Koontz, Bridget Koontz, Bridget Less Oncology Times. 38(4):25, February 25, 2016. Favorites PDF Get Content & Permissions Free
3 Questions on... Making Clinical Trial Demographic Data More Transparent DiGiulio, Sarah DiGiulio, Sarah Less Oncology Times. 38(4):40, February 25, 2016. Favorites PDF Get Content & Permissions Free
Shop Talk Less Oncology Times. 38(4):41-42, February 25, 2016. Favorites PDF Get Content & Permissions Free
Protocol Alert Less Oncology Times. 38(4):18-21, February 25, 2016. Favorites PDF Get Content & Permissions Free
